Riskpilot← Back to searchSign inGet full accessLancell AB
ABActiveOrg 5591012348StockholmResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20170 employees
Revenue 2024
—
EBITDA margin
—
+71% vs 2023
Equity ratio
45.7%
Financial strength
Net profit 2024
SEK -110K
+73% vs 2023
| Revenue | — | — |
| EBITDA | SEK -119K | +71% |
| Net profit | SEK -110K | +73% |
| Total assets | SEK 1,5M | +79% |
| Equity | SEK 685K | -14% |
| Employees | 0 | — |
Legal name
Lancell AB
Org number
5591012348
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
17 februari 2017
Share capital
SEK 60 900
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Zhao, Jingcheng
Company purpose
Aktiebolaget ska bedriva forskning, utveckling, produktion och försäljning inom biomedicin och bioteknik liksom idka därmed förenlig verksamhet.
Address
Stockholm
Email
jingcheng.zhao@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | — | — | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −122 | −108 | −187 | −414 | −119 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −122 | −108 | −187 | −414 | −119 |
| Net financials | — | — | 0 | 11 | 9 |
| Profit before tax | −122 | −108 | −187 | −403 | −110 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −122 | −108 | −187 | −403 | −110 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 202 | 93 | 207 | 840 | 1 500 |
| Equity | 195 | 86 | 200 | 795 | 685 |
| Long-term debt | 0 | 0 | — | — | 800 |
| Short-term debt | 7 | 7 | 7 | 45 | 15 |
| Total debt | 7 | 7 | 7 | 45 | 815 |
EBITDA margin
-11943400.0%
This company
15.8%
Market median
-75591239% vs market
20202024
Equity ratio
45.7%
This company
38.2%
Market median
+20% vs market
20202024
Return on equity
-16.1%
This company
18.4%
Market median
-188% vs market
20202024
Net profit margin
-11019500.0%
This company
8.1%
Market median
-136043310% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.19×
This company
0.62×
Market median
-92% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lancell AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Xiaojun Lian | Board of Directors | 0 companies |
| Jingcheng Zhao | Chairman | 0 companies |
| Hans Jockum Hultén | Deputy Board Member | 0 companies |